MicroRNA profiles to predict postoperative prognosis in patients with small cell carcinoma of the esophagus

Anticancer Research

Volumn 35, Issue 2, 2015, Pages 719-727

  Okumura, Tomoyuki ^a   Shimada, Yutaka ^a,b   Omura, Tetsuya ^a   Hirano, Katsuhisa ^a   Nagata, Takuya ^a   Tsukada, Kazuhiro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Esophageal cancer; miRNA; Prognostic marker; Small cell carcinoma; Surgery

Indexed keywords

MICRORNA;

AGED; CARCINOMA, SMALL CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS;

EID: 84923648082     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kukar M, Groman A, Malhotra U, Warren GW, Bogner P, Nwogu CE, Demmy TL and Yendamuri S: Small cell carcinoma of the esophagus: a SEER database analysis. Ann Surg Oncol 20: 4239-4244, 2013.
2. Al Mansoor S, Ziske C and Schmidt-Wolf IG: Primary small cell carcinoma of the esophagus: patient data meta analysis and review of the literature. Ger Med Sci 11, 2013.
3. Chen SB, Yang JS, Yang WP, Weng HR, Li H, Liu DT and Chen YP: Treatment and prognosis of limited disease primary small cell carcinoma of esophagus. Dis Esophagus 24: 114-119, 2011.
4. Gao R, Zhang Y, Wen XP, Fu J and Zhang GJ: Chemotherapy with cisplatin or carboplatin in combination with etoposide for small-cell esophageal cancer: a systemic analysis of case series. Dis Esophagus 2013. doi: 10.1111/dote.12149. Epub ahead of print
5. Zhu Y, Qiu B, Liu H, Li Q, Xiao W, Hu Y and Liu M: Primary small cell carcinoma of the esophagus: review of 64 cases from a single institution. Dis Esophagus 27: 152-158, 2014.
6. Baek D, Villén J, Shin C, Camargo FD, Gygi SP and Bartel DP: The impact of microRNAs on protein output. Nature 455: 64-71, 2008.
7. Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM and Xu LY: MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J Surg Oncol 105: 175-182, 2012.
8. Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X, Li B, Meng X, Ma X, Luo M, Shao K, Li N, Qiu B, Mitchelson K, Cheng J and He J: Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 68: 26-33, 2008.
9. Sobin LH, Gospodarowicz M and Wittekind C, (editors): TNM Classification of Malignant Tumours, 7th Edition, UICC International Union Against Cancer 2010. Hoboken, NJ: Wiley-Blackwell; 2010.
10. Osawa S, Shimada Y, Sekine S, Okumura T, Nagata T, Fukuoka J and Tsukada K: MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples. Oncol Lett 2: 613-619, 2011.
11. Shimada Y, Imamura M, Wagata T, Yamaguchi N and Tobe T: Characterization of 21 newly established esophageal cancer cell lines. Cancer 69: 277-284, 1992.
12. Zhao WX and Luo JF: Serum neuron-specific enolase levels were associated with the prognosis of small cell lung cancer: a meta-analysis. Tumour Biol 34: 3245-3248, 2013.
13. Ranade AR, Cherba D, Sridhar S, Richardson P, Webb C, Paripati A, Bowles B and Weiss GJ: MicroRNA 92a-2∗: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J Thorac Oncol 5: 1273-1278, 2010.
14. Xu XL, Jiang YH, Feng JG, Su D, Chen PC and Mao WM: MicroRNA-17, MicroRNA-18a, and MicroRNA-19a Are Prognostic Indicators in Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 97: 1037-1045, 2013.
15. Nouraee N, Van Roosbroeck K, Vasei M, Semnani S, Samaei NM, Naghshvar F, Omidi AA, Calin GA and Mowla SJ: Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma. PLoS One 8: e73009, 2013. doi: 10.1371/journal.pone.0073009.
16. Li X, Yang C, Wang X, Zhang J, Zhang R and Liu R: Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma. PLoS One 8: e73009, 2013. doi: 10.1371/journal.pone.0073009.
17. Gu J, Wang Y and Wu X: MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr Pharm Des 19: 1292-1300, 2013.
18. Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, Komatsu A, Jitsukawa M and Matsubara H: Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer 108: 644-652, 2013.
19. Chen J, Yao D, Li Y, Chen H, He C, Ding N, Lu Y, Ou T, Zhao S, Li L and Long F: Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int J Mol Med 32: 557-567, 2013.
20. Mathé EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, Altorki NK, Casson AG, Liu CG, Wang XW, Yanaihara N, Hagiwara N, Dannenberg AJ, Miyashita M, Croce CM and Harris CC: MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 15: 6192-6200, 2009.
21. Okumura T, Shimada Y, Moriyama M, Takei Y, Omura T, Sekine S, Nagata T, Shimizu K and Tsukada K: MicroRNA-203 inhibits the progression of esophageal squamous cell carcinoma with restored epithelial tissue architecture in vivo. Int J Oncol 44: 1923-1932, 2014.
22. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and Matsubara H: miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814, 2010.
23. Rasmussen MH, Jensen NF, Tarpgaard LS, Qvortrup C, Rømer MU, Stenvang J, Hansen TP, Christensen LL, Lindebjerg J, Hansen F, Jensen BV, Hansen TF, Pfeiffer P, Brünner N, Ørntoft TF and Andersen CL: High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer. Mol Oncol 7: 637-646, 2013.
24. Kirschner MB1, Cheng YY, Badrian B, Kao SC, Creaney J, Edelman JJ, Armstrong NJ, Vallely MP, Musk AW, Robinson BW, McCaughan BC, Klebe S, Mutsaers SE, van Zandwijk N, Reid G: Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma. J Thorac Oncol 7: 1184-1191, 2012.
25. Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z, Sun J, Tan FW, Ding DP, Xu XH, Zhou F, Tan XG, Hang J, Shi SS, Feng XL and He J: microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J Biol Chem 286: 10725-10734, 2011.
26. Kozinn SI, Harty NJ, Delong JM, Deliyiannis C, Logvinenko T, Summerhayes IC, Libertino JA, Holway AH and Rieger-Christ KM: MicroRNA Profile to Predict Gemcitabine Resistance in Bladder Carcinoma Cell Lines. Genes Cancer 4: 61-69, 2013.
27. Zhang B, Chen J, Ren Z, Chen Y, Li J, Miao X, Song Y, Zhao T, Li Y, Shi Y, Ren D and Liu J: A specific miRNA signature promotes radioresistance of human cervical cancer cells. Cancer Cell Int 13: 118, 2013.
28. Huang YH, Lin KH, Chen HC, Chang ML, Hsu CW, Lai MW, Chen TC, Lee WC, Tseng YH, Yeh CT: Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma. PLoS One 7: e37188, 2012. doi: 10.1371
29. Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA and Xu XC: Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 128: 132-143, 2011.
30. Navarro A, Diaz T, Gallardo E, Viñolas N, Marrades RM, Gel B, Campayo M, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J and Monzo M: Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer. J Surg Oncol 103: 411-415, 2011.
31. Omura T, Shimada Y, Nagata T, Okumura T, Fukuoka J, Yamagishi F, Tajika S, Nakajima S, Kawabe A and Tsukada K: Relapse-associated microRNA in gastric cancer patients after S-1 adjuvant chemotherapy. Oncol Rep 31: 613-618, 2014.
32. Mrózek K, Whitman SP, Metzeler KH, Mendler JH, Wu YZ, Liyanarachchi S, Patel R, Baer MR, Powell BL, Carter TH, Moore JO, Kolitz JE, Wetzler M, Caligiuri MA, Larson RA, Tanner SM, de la Chapelle A and Bloomfield CD: miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia. Blood 120: 249-258, 2012.
33. Katayama Y, Maeda M, Miyaguchi K, Nemoto S, Yasen M, Tanaka S, Mizushima H, Fukuoka Y, Arii S and Tanaka H: Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling. Oncol Lett 4: 817-823, 2012.
34. Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ, Wang TY, Li HC and Wu XN: Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett 5: 1639-1642, 2013.
35. Hirata H, Hinoda Y, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL and Dahiya R: Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells. Br J Cancer 110: 1645-1654, 2014.
36. Liu RY, Diao CF, Zhang Y, Wu N, Wan HY, Nong XY, Liu M and Tang H: miR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma cells. Cancer Lett 335: 351-360, 2013.
37. Li T, Lu YY, Zhao XD, Guo HQ, Liu CH, Li H, Zhou L, Han YN, Wu KC, Nie YZ, Shi YQ and Fan DM: MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1. Oncogene 33: 783-793, 2014.
38. Zhou C, Yu Q, Chen L, Wang J, Zheng S and Zhang J: A miR-1231 binding site polymorphism in the 3'UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility. Gene 507: 95-98, 2012.